Skip to main content
Top
Published in: BMC Pediatrics 1/2009

Open Access 01-12-2009 | Research article

Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index

Authors: Christine Trivin, Kanetee Busiah, Nizar Mahlaoui, Christophe Recasens, Jean-Claude Souberbielle, Michel Zerah, Christian Sainte-Rose, Raja Brauner

Published in: BMC Pediatrics | Issue 1/2009

Login to get access

Abstract

Background

Obesity seems to be linked to the hypothalamic involvement in craniopharyngioma. We evaluated the pre-surgery relationship between the degree of this involvement on magnetic resonance imaging and insulin resistance, as evaluated by the homeostasis model insulin resistance index (HOMA). As insulin-like growth factor 1, leptin, soluble leptin receptor (sOB-R) and ghrelin may also be involved, we compared their plasma concentrations and their link to weight change.

Methods

27 children with craniopharyngioma were classified as either grade 0 (n = 7, no hypothalamic involvement), grade 1 (n = 8, compression without involvement), or grade 2 (n = 12, severe involvement).

Results

Despite having similar body mass indexes (BMI), the grade 2 patients had higher glucose, insulin and HOMA before surgery than the grade 0 (P = 0.02, <0.05 and 0.02 respectively) and 1 patients (P < 0.02 and <0.03 for both insulin and HOMA). The grade 0 (5.8 ± 4.9) and 1 (7.2 ± 5.3) patients gained significantly less weight (kg) during the year after surgery than did the grade 2 (16.3 ± 7.4) patients. The pre-surgery HOMA was positively correlated with these weight changes (P < 0.03).
The data for the whole population before and 6–18 months after surgery showed increases in BMI (P < 0.0001), insulin (P < 0.005), and leptin (P = 0.0005), and decreases in sOB-R (P < 0.04) and ghrelin (P < 0.03).

Conclusion

The hypothalamic involvement by the craniopharyngioma before surgery seems to determine the degree of insulin resistance, regardless of the BMI. The pre-surgery HOMA values were correlated with the post-surgery weight gain. This suggests that obesity should be prevented by reducing inn secretion in those cases with hypothalamic involvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE: Risk Factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003, 88: 611-616. 10.1210/jc.2002-021180.CrossRefPubMed Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE: Risk Factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003, 88: 611-616. 10.1210/jc.2002-021180.CrossRefPubMed
2.
go back to reference Talvensaari KK, Lanning M, Tapanainen P, Knip M: Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996, 81: 3051-3055. 10.1210/jc.81.8.3051.PubMed Talvensaari KK, Lanning M, Tapanainen P, Knip M: Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996, 81: 3051-3055. 10.1210/jc.81.8.3051.PubMed
3.
go back to reference Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, Youngren NM, Glasser SP, Baker KS: Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006, 107: 1303-1312. 10.1002/cncr.22120.CrossRefPubMed Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, Youngren NM, Glasser SP, Baker KS: Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006, 107: 1303-1312. 10.1002/cncr.22120.CrossRefPubMed
4.
go back to reference Adams LA, Feldstein A, Lindor KD, Angulo P: Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology. 2004, 39: 909-914. 10.1002/hep.20140.CrossRefPubMed Adams LA, Feldstein A, Lindor KD, Angulo P: Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology. 2004, 39: 909-914. 10.1002/hep.20140.CrossRefPubMed
5.
go back to reference Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE: Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999, 135: 162-168. 10.1016/S0022-3476(99)70017-X.CrossRefPubMed Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE: Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999, 135: 162-168. 10.1016/S0022-3476(99)70017-X.CrossRefPubMed
6.
go back to reference Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X: Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2003, 88: 2586-2592. 10.1210/jc.2002-030003.CrossRefPubMed Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X: Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2003, 88: 2586-2592. 10.1210/jc.2002-030003.CrossRefPubMed
7.
go back to reference Jeanrenaud B: Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology. Metabolism. 1978, 27 (12 Suppl 2): 1881-1892. 10.1016/S0026-0495(78)80006-7.CrossRefPubMed Jeanrenaud B: Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology. Metabolism. 1978, 27 (12 Suppl 2): 1881-1892. 10.1016/S0026-0495(78)80006-7.CrossRefPubMed
8.
go back to reference Inoue S, Bray GA: The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology. 1977, 100: 108-114.CrossRefPubMed Inoue S, Bray GA: The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology. 1977, 100: 108-114.CrossRefPubMed
9.
go back to reference De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R: Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab. 1996, 81: 2734-2737. 10.1210/jc.81.7.2734.PubMed De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R: Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab. 1996, 81: 2734-2737. 10.1210/jc.81.7.2734.PubMed
10.
go back to reference Meuric S, Brauner R, Trivin C, Souberbielle J-C, Zerah M, Sainte-Rose C: Influence of tumor location on the presentation and evolution of craniopharyngiomas. J Neurosurg. 2005, 103 (5 suppl): 421-426.PubMed Meuric S, Brauner R, Trivin C, Souberbielle J-C, Zerah M, Sainte-Rose C: Influence of tumor location on the presentation and evolution of craniopharyngiomas. J Neurosurg. 2005, 103 (5 suppl): 421-426.PubMed
11.
go back to reference Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G: Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life. Klin Pädiatr. 2001, 213: 244-249. 10.1055/s-2001-16855.CrossRefPubMed Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G: Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life. Klin Pädiatr. 2001, 213: 244-249. 10.1055/s-2001-16855.CrossRefPubMed
12.
go back to reference Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N: Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2003, 89: 3298-3305. 10.1210/jc.2003-031751.CrossRef Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N: Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2003, 89: 3298-3305. 10.1210/jc.2003-031751.CrossRef
13.
go back to reference Pinto G, Bussières L, Recasens C, Souberbielle J-C, Zerah M, Brauner R: Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res. 2000, 53: 163-169. 10.1159/000023562.CrossRefPubMed Pinto G, Bussières L, Recasens C, Souberbielle J-C, Zerah M, Brauner R: Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res. 2000, 53: 163-169. 10.1159/000023562.CrossRefPubMed
14.
go back to reference Brabant G, Horn R, Mayr B, von zur Mühlen A, Honegger J, Buchfelder M: Serum leptin levels following hypothalamic surgery. Horm Metab Res. 1996, 28: 728-731. 10.1055/s-2007-979888.CrossRefPubMed Brabant G, Horn R, Mayr B, von zur Mühlen A, Honegger J, Buchfelder M: Serum leptin levels following hypothalamic surgery. Horm Metab Res. 1996, 28: 728-731. 10.1055/s-2007-979888.CrossRefPubMed
15.
go back to reference Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U: Hyperphagia in children with craniopharyngioma is associated with hyperleptinemia and a failure in the downregulation of appetite. Eur J Endocrinol. 1998, 138: 89-91. 10.1530/eje.0.1380089.CrossRefPubMed Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U: Hyperphagia in children with craniopharyngioma is associated with hyperleptinemia and a failure in the downregulation of appetite. Eur J Endocrinol. 1998, 138: 89-91. 10.1530/eje.0.1380089.CrossRefPubMed
16.
go back to reference Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB, Korbonits M: Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3–36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab. 2005, 90: 2681-2690. 10.1210/jc.2003-032209.CrossRefPubMed Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB, Korbonits M: Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3–36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab. 2005, 90: 2681-2690. 10.1210/jc.2003-032209.CrossRefPubMed
17.
go back to reference Kanumakala S, Greaves R, Pedreira CC, Donath S, Warne GL, Zacharin MR, Harris M: Fasting ghrelin levels are not elevated in children with hypothalamic obesity. J Clin Endocrinol Metab. 2005, 90: 2691-2695. 10.1210/jc.2004-2175.CrossRefPubMed Kanumakala S, Greaves R, Pedreira CC, Donath S, Warne GL, Zacharin MR, Harris M: Fasting ghrelin levels are not elevated in children with hypothalamic obesity. J Clin Endocrinol Metab. 2005, 90: 2691-2695. 10.1210/jc.2004-2175.CrossRefPubMed
18.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
19.
go back to reference Sempé M, Pedron G, Roy-Pernot MP: Auxologie, méthode et séquences. 1979, Paris. Théraplix Sempé M, Pedron G, Roy-Pernot MP: Auxologie, méthode et séquences. 1979, Paris. Théraplix
20.
go back to reference Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A: Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991, 45: 13-21.PubMed Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A: Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991, 45: 13-21.PubMed
21.
go back to reference Bussières L, Souberbielle J-C, Pinto G, Adan L, Noël M, Brauner R: The use of insulin like growth factor I reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol. 2000, 52: 735-739. 10.1046/j.1365-2265.2000.00999.x.CrossRef Bussières L, Souberbielle J-C, Pinto G, Adan L, Noël M, Brauner R: The use of insulin like growth factor I reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol. 2000, 52: 735-739. 10.1046/j.1365-2265.2000.00999.x.CrossRef
22.
go back to reference Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT: Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004, 89: 81-86. 10.1210/jc.2003-030442.CrossRefPubMed Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT: Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004, 89: 81-86. 10.1210/jc.2003-030442.CrossRefPubMed
23.
go back to reference Brauner R, Trivin C, Zerah M, Souberbielle J-C, Doz F, Kalifa C, Sainte-Rose C: Diencephalic syndrome due to hypothalamic tumor: a model of the relationship between weight and puberty onset. J Clin Endocrinol Metab. 2006, 91: 2467-2473. 10.1210/jc.2006-0322.CrossRefPubMed Brauner R, Trivin C, Zerah M, Souberbielle J-C, Doz F, Kalifa C, Sainte-Rose C: Diencephalic syndrome due to hypothalamic tumor: a model of the relationship between weight and puberty onset. J Clin Endocrinol Metab. 2006, 91: 2467-2473. 10.1210/jc.2006-0322.CrossRefPubMed
24.
go back to reference Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B: Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab. 2004, 89: 5435-5440. 10.1210/jc.2004-0667.CrossRefPubMed Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B: Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab. 2004, 89: 5435-5440. 10.1210/jc.2004-0667.CrossRefPubMed
25.
go back to reference Mason PW, Krawiecki N, Meacham LR: The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med. 2002, 156: 887-892.CrossRefPubMed Mason PW, Krawiecki N, Meacham LR: The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med. 2002, 156: 887-892.CrossRefPubMed
26.
go back to reference Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE: Beneficial effect of Diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab. 1998, 83: 1911-1915. 10.1210/jc.83.6.1911.PubMed Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE: Beneficial effect of Diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab. 1998, 83: 1911-1915. 10.1210/jc.83.6.1911.PubMed
Metadata
Title
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index
Authors
Christine Trivin
Kanetee Busiah
Nizar Mahlaoui
Christophe Recasens
Jean-Claude Souberbielle
Michel Zerah
Christian Sainte-Rose
Raja Brauner
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2009
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-9-24

Other articles of this Issue 1/2009

BMC Pediatrics 1/2009 Go to the issue